The FDA's Arthritis Advisory Committee struggled to flip its mind around a broad novel indication of axial spondyloarthritis (axSpA) Tuesday, voting 7-6, with one abstention, to recommend FDA approval ...
Inadequate Initial Response is the Top Reason Why Rheumatologists Move Patients from Simponi and Cimzia, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 7, 2010 /PRNewswire/ ...
Nov 15 (Reuters) - UCB SA : * The Lancet publishes first head-to-head study of Cimzia (certolizumab pegol) and Humira (adalimumab) in bio-naïve rheumatoid arthritis patients Sign up here. * Study did ...
How Do I Use Cimzia? Cimzia is a liquid that is injected under the skin every 2 to 4 weeks. The dose and how often you use the medication will be determined by your health care provider. It can be ...
EXTON, Pa., July 21 /PRNewswire/ -- BioTrends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Rheumatoid Arthritis 2Q 2010. This report covers the use of biologics ...
WASHINGTON - The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the ...
Shares of Belgium's UCB shot up after the company announced that the FDA had approved its blockbuster rheumatoid arthritis drug Cimzia. The drug, which the patient can inject himself using a prefilled ...
Sept. 5 -- THURSDAY, Sept. 4 (HealthDay News) -- Federal health authorities have asked the manufacturers of four widely used immunosuppressive drugs to bolster safety warnings on the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback